(Q33636611)

28 July 2017

1 reference

title

Relationship of pharmacokinetics to clinical outcomes (English)

1 reference

28 July 2017

1 reference

Levy GA

1

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 May 1999

1 reference

Transplantation Proceedings

28 July 2017

published in

1 reference

28 July 2017

volume

31

1 reference

28 July 2017

issue

3

1 reference

28 July 2017

page(s)

1654-1658

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900086-X

28 July 2017

1 reference

7 January 2021

Intraindividual variability in the relative systemic availability of cyclosporin after oral dosing

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900086-X

7 January 2021

The adverse impact of high cyclosporine. Clearance rates on the incidences of acute rejection and graft loss

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900086-X

7 January 2021

Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900086-X

7 January 2021

Neoral in de novo liver transplantation: adequate immunosuppression without intravenous cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900086-X

7 January 2021

Effect of bile on cyclosporin absorption in liver transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900086-X

7 January 2021

Cyclosporin A pharmacokinetics in liver transplant recipients in relation to biliary T-tube clamping and liver dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900086-X

7 January 2021

Gene therapy. Clinical potential and relationship to drug treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900086-X

7 January 2021

Improved dose linearity of cyclosporine pharmacokinetics from a microemulsion formulation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900086-X

7 January 2021

A randomized, prospective multicenter pharmacoepidemiologic study of cyclosporine microemulsion in stable renal graft recipients. Report of the Canadian Neoral Renal Transplantation Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900086-X

7 January 2021

A microemulsion of cyclosporine without intravenous cyclosporine in liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900086-X

7 January 2021

Comparative bioavailability of Neoral and Sandimmune in cardiac transplant recipients over 1 year

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900086-X

7 January 2021

Neoral vs Sandimmun: interim results of a randomized trial of efficacy and safety in preventing acute rejection in new renal transplant recipients. The U. K. Neoral Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900086-X

7 January 2021

Reduced acute rejection after liver transplantation with Neoral-based triple immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900086-X

7 January 2021

Factors Influencing the Pharmacokinetics of Cyclosporine in Man

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900086-X

7 January 2021

10.1016/S0041-1345(99)00086-X

Identifiers

DOI

1 reference

28 July 2017

1 reference